Heart failure drug JARDIANCE passes Long-Term safety check in japan
NCT ID NCT05262764
First seen Apr 04, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study tracked 1,200 Japanese adults with chronic heart failure who took JARDIANCE tablets daily for a long time. Researchers monitored side effects like low blood sugar, dehydration, and kidney issues, as well as deaths and hospitalizations. The goal was to see how safe and effective the drug is in everyday use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nippon Boehringer Ingelheim Co., Ltd.
Tokyo, 1416017, Japan
Conditions
Explore the condition pages connected to this study.